Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group

  1. Martin, M.
  2. Villar, A.
  3. Sole-Calvo, A.
  4. Gonzalez, R.
  5. Massuti, B.
  6. Lizon, J.
  7. Camps, C.
  8. Carrato, A.
  9. Casado, A.
  10. Candel, M.T.
  11. Albanell, J.
  12. Aranda, J.
  13. Munarriz, B.
  14. Campbell, J.
  15. Diaz-Rubio, E.
Aldizkaria:
Annals of Oncology

ISSN: 0923-7534

Argitalpen urtea: 2003

Alea: 14

Zenbakia: 6

Orrialdeak: 833-842

Mota: Artikulua

DOI: 10.1093/ANNONC/MDG260 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus